Better Therapeutics, Inc. (BTTX) Deferred Tax Assets, Valuation Allowance USD 2020 - 2022

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Better Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2022.
Better Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $14.7 M, a 132% increase year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$14.7 M	+$8.36 M	+132%	Dec 31, 2022	10-K	2023-03-30
Q4 2021	$6.35 M	+$6.26 M	+7367%	Dec 31, 2021	10-K	2023-03-30
Q4 2020	$85 K			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.